COMMUNIQUÉS West-GlobeNewswire

CymaBay Reports Second Quarter 2018 Financial Results and Provides Corporate Update

09/08/2018 - 22:01

Conference call and webcast today at 4:30p.m. ET NEWARK, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY) a clinical-stage biopharmaceutical company focused on developing therapies for [...]

Ovid Therapeutics Reports Second Quarter 2018 Financial Results and Highlights Recent Clinical Progress

09/08/2018 - 22:01

-- OV101 in Angelman syndrome: plan to initiate an open-label extension study (ELARA) in the fourth quarter of 2018 and discuss with regulatory authorities next steps for a registrational pathway based on positive Phase [...]

Corium Reports Third Quarter Fiscal 2018 Financial Results and Corporate Highlights

09/08/2018 - 22:01

MENLO PARK, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq: CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty [...]

Cytori Reports Publication of Interim Pilot Data for Cell Therapy in Vocal Fold Scarring

09/08/2018 - 15:25

SAN DIEGO, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) announced publication in the peer-reviewed journal, Stem Cell Research and Therapy, of “Autologous adipose-derived stromal vascular [...]

RedHill Biopharma Announces Pricing of $25 Million Underwritten Offering

09/08/2018 - 15:09

TEL-AVIV, Israel and RALEIGH, N.C., Aug. 09, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]

Vaccinex Announces Pricing of Initial Public Offering

09/08/2018 - 15:08

ROCHESTER, N.Y., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Vaccinex), a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and [...]

Healthwise Announces Jay Reynolds as Chief Technology Officer

09/08/2018 - 15:07

BOISE, Idaho, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Healthwise, a leader in evidence-based health education, technology and services, announced that Jay Reynolds has assumed the position of Chief Technology Officer (CTO). [...]

Sienna Biopharmaceuticals Reports Second Quarter 2018 Financial Results

09/08/2018 - 15:05

WESTLAKE VILLAGE, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA), a clinical-stage medical dermatology and aesthetics company, today reported the Company’s financial results for [...]

Medtronic Begins Pilot Study of Investigational Extravascular ICD System

09/08/2018 - 15:01

Chronic Study Evaluating New ICD System Designed to Deliver Pacing and Defibrillation Therapy Via a Lead Placed Under the Sternum, Outside the Heart and Veins DUBLIN - August 9, 2018 - Medtronic plc (NYSE:MDT) today [...]

Aptevo Therapeutics Reports Second Quarter 2018 Financial Results

09/08/2018 - 15:00

Achieves Record IXINITY ® Net Revenue with 94% Increase in Year-Over-Year Quarterly Revenue Publishes and Presents New Data on Multiple ADAPTIR™ Bispecific Candidates Showing Robust Immune System Engagement and T-cell [...]

BioStem Technologies, Inc. (BSEM) Launches New Subsidiary to Engage in the Processing and Supply of Regenerative Tissue Products

09/08/2018 - 15:00

Pompano Beach, FL, Aug. 09, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), BioStem Technologies, Inc. is a global life sciences corporation, providing innovative [...]

Athenex Pharmaceutical Division Receives FDA Clearance to Import Potassium Chloride Injection Concentrate to Address U.S. Drug Shortage

09/08/2018 - 15:00

BUFFALO, N.Y., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 8 August 2018

09/08/2018 - 14:38

Bagsværd, Denmark, 9 August 2018 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 [...]

Precision Therapeutics Investee, Helomics Corporation, Launches Precision Oncology Insights Platform

09/08/2018 - 14:30

MINNEAPOLIS, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery [...]

PolarityTE, Inc. Announces the Addition of Ramses Erdtmann, Managing Partner at Point Sur Investors and Former Executive at Pharmacyclics, and David Seaburg, Managing Director at Cowen and CNBC Contributor, to the Board of Directors

09/08/2018 - 14:30

SALT LAKE CITY, Aug. 09, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq: COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, [...]

Arbutus to Present at the 2018 Wedbush PacGrow Healthcare Conference

09/08/2018 - 14:30

WARMINSTER, Pa., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that Dr. Michael Sofia, Arbutus [...]

Fluidigm to Host 2nd Annual Imaging Mass Cytometry User Group Meeting

09/08/2018 - 14:30

Leading translational and clinical researchers to share new insights and best practices using Imaging Mass Cytometry SOUTH SAN FRANCISCO, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation, a leader in mass [...]

Pressure BioSciences, Inc. President and CEO, Richard T. Schumacher, Discusses Recent Company Achievements with Everett Jolly on Uptick Newswire’s “Stock Day” Podcast

09/08/2018 - 14:30

PHOENIX, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Uptick Newswire today announced the release of an interview with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB:PBIO) (the “Company”) on Uptick [...]

Auris Medical to Report Second Quarter 2018 Financial Results and Provide Business and Update on Wednesday, August 15, 2018

09/08/2018 - 14:01

Zug, Switzerland, August 09, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and mental health [...]